Concentration of soluble adhesion molecules (sVCAM-1, sICAM-1 and sL-Selectin) in the cerebrospinal fluid and serum of patients with multiple sclerosis and systemic lupus erythematosus with central nervous involvement
K. Baraczka et al., Concentration of soluble adhesion molecules (sVCAM-1, sICAM-1 and sL-Selectin) in the cerebrospinal fluid and serum of patients with multiple sclerosis and systemic lupus erythematosus with central nervous involvement, NEUROIMMUNO, 9(1), 2001, pp. 49-54
Objectives: The aim of the present study was to investigate the role of sol
uble adhesion molecules in the pathogenesis of multiple sclerosis (MS) and
systemic lupus erythematosus (SLE) with demyelinating syndrome. Methods: Pa
ired cerebrospinal fluid (CSF) and serum samples were analysed by an ELISA
method to determine the concentrations of sVCAM-1, sICAM-1 and sL-selectin.
Intrathecal syntheses of the adhesion molecules were calculated. Results:
Elevated serum and CSF concentrations of sVCAM-1 were present in all patien
t groups. Intrathecal synthesis of sVCAM-1 was present in the relapsing-rem
itting and secondary progressive forms of MS. Intrathecal synthesis of sICA
M-1 was observed in all clinical forms of MS. MS patients with progressive
forms of the disease and SLE patients were characterised by intrathecal syn
thesis of sL-selectin. Conclusions: The data presented suggest that (1) blo
od-brain barrier damage can be assumed both in systemic disease and organ-s
pecific disease (sVCAM-1), (2) clinical forms of MS differ from each other
in respect to concentrations of adhesion molecules and (3) similar immunolo
gical events in the central nervous system of SLE patients with demyelinati
ng syndrome and progressive forms of MS can be assumed (sL-selectin). Copyr
ight (C) 2001 S. Karger AG, Basel.